intravitreal injection of conbercept

DRUG3 trials

Sponsors

Sun Yat-sen University, Xun Xu, Peking Union Medical College Hospital

Conditions

Age-Related Macular DegenerationConberceptEffect of DrugsMacular EdemaPathological MyopiaPharmacogenomicPolypoidal Choroidal VasculopathyProliferative Diabetic Retinopathy

Phase 2

Effects of Conbercept in Refractory Uveitic Macular Edema and VEGF

TerminatedNCT04296838

Peking Union Medical College HospitalEffect of Drugs, Macular Edema, Uveitis +1

Start: 2019-10-12End: 2022-02-12Updated: 2022-10-25

Unknown Phase

Conbercept vs Panretinal Photocoagulation for the Management of Proliferative Diabetic Retinopathy

Sun Yat-sen UniversityProliferative Diabetic Retinopathy

Start: 2019-10-12End: 2022-12-31Target: 226Updated: 2021-02-25

Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases

Xun XuAge-Related Macular Degeneration, Conbercept, Pathological Myopia +2

Start: 2017-02-28End: 2018-12-31Target: 5000Updated: 2017-04-25

Related Papers

Dysregulated serum lipid profiles in neovascular age-related macular degeneration revealed by UPLC‒MS/MS lipidomics.

2025-09-29

Pharmacogenomic study on anti-VEGF medicine in treatment of macular Neovascular diseases: a study protocol for a prospective observational study.

2018-07-243 citations